B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients

scientific article published on 01 December 2008

B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CLC.20336
P932PMC publication ID6653402
P698PubMed publication ID19072881

P2093author name stringGuy Amit
Doron Zahger
Amos Katz
Ori Galante
Reuben Ilia
Abraham Wagshal
P2860cites workProphylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fractionQ28208692
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmiasQ33175452
Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT.Q34119607
Plasma natriuretic peptide levels and the risk of cardiovascular events and deathQ34298401
Cost-effectiveness of implantable cardioverter-defibrillators.Q34457211
Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapiesQ35771323
Effects of mechanosensitive ion channels on ventricular electrophysiology: experimental and theoretical modelsQ36366174
B-type natriuretic peptide predicts sudden death in patients with chronic heart failureQ43703424
Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.Q43837664
Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) studyQ44478626
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarctionQ48155813
Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillatorsQ48723291
P433issue12
P304page(s)586-589
P577publication date2008-12-01
P1433published inClinical CardiologyQ4502312
P1476titleB-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients
P478volume31

Reverse relations

cites work (P2860)
Q42339382Changes of Atrial Natriuretic Peptides after Defibrillation Threshold Testing Predicted Future Ventricular Arrhythmia Event.
Q37020211Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy
Q37035544Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association

Search more.